Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 8Breast 5Dermatologic 4Head & Neck 3Sarcoma 2Thoracic 1Myeloid 1Lymphoid 1Gynecologic 1Endocrine 1Classical hematology 1CNS 1

Conditions

Brain Neoplasms 1699Glioblastoma 1307Glioma 992Neuroblastoma 408Central Nervous System Neoplasms 384Astrocytoma 383Gliosarcoma 286Oligodendroglioma 237Neoplasms 226Breast Neoplasms 216Meningioma 179Medulloblastoma 172Carcinoma, Non-Small-Cell Lung 149Recurrence 147Neoplasm Metastasis 138Lung Neoplasms 138Ependymoma 127Melanoma 118Sarcoma 116Neurofibromatosis 1 110Meningeal Carcinomatosis 107Lymphoma 94Neuroma, Acoustic 82Diffuse Intrinsic Pontine Glioma 81Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Head and Neck Neoplasms 79Ovarian Neoplasms 73Lymphoma, Follicular 73Pheochromocytoma 71Paraganglioma 68

Interventions

Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hereditary Sensory and Autonomic Neuropathies × CNS × Clear all
NCT00411619 2014-10-20

Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex

Children's Hospital Medical Center, Cincinnati

Phase 1/2 Completed
28 enrolled 7 charts
CNS

Astrocytoma, Hereditary Sensory and Autonomic Neuropathies, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡